8 research outputs found

    Characteristics of HIV infected persons interviewed about adherence to currently prescribed antiretroviral therapy, number and proportion of nonadherent respondents, and logistic regression model of factors associated with nonadherence among 5,887 respondents to the Supplement to HIV/AIDS Surveillance Project, 18 US States, 2000 to 2004

    No full text
    <p>ARVT: antiretroviral therapy; PI: protease inhibitor; HAART: Highly active antiretroviral therapy.</p>*<p>Referent group is all other races</p>†<p>Referent group is ≥40 years</p>‡<p>Confidence interval excludes 1.0; lower bound is rounded down to 1.0.</p>§<p>Referent group is all other risks</p>∥<p>Referent group is all other places of residence</p>¶<p>Any use in the 12 months before the interview</p>**<p>Referent group is duration of ARVT treatment <21 months</p>††<p>Referent group is currently prescribed 1–3 drugs</p>‡‡<p>Referent group is any other prescribed regimen</p

    Medical Monitoring Project Data Domains, 2007*

    No full text
    *<p>Complete interview and chart abstraction instruments are available at: <a href="http://www.cdc.gov/hiv/topics/treatment/MMP/index.htm" target="_blank">http://www.cdc.gov/hiv/topics/treatment/MMP/index.htm</a></p

    Racial/Ethnic Distribution of Adults* Living with HIV/AIDS in the United States, 2003, and in US HIV Cohorts, 2003-2006

    No full text
    *<p>Aged 13 and older in ASD and the US living HIV/AIDS cases, 18 and older in SHAS</p>†<p>Estimated number of persons living with HIV/AIDS at the end of 2003 from 33 areas with confidential name-based HIV infection reporting</p>‡<p>Not available: data on patients with Hispanic ethnicity are not reported in cohort profile <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0000550#pone.0000550-Gange1" target="_blank">[40]</a></p
    corecore